Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line

por Omotehara, F, Kawamata, H, Uchida, D, Hino, S, Nakashiro, K, Fujimori, T
Publicado 2002

Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.

por Kawamata, H., Nakashiro, K., Uchida, D., Hino, S., Omotehara, F., Yoshida, H., Sato, M.
Publicado 1998

Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients

por Kawamata, H, Uchida, D, Nakashiro, K, Hino, S, Omotehara, F, Yoshida, H, Sato, M
Publicado 1999

Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines

por Uchida, D, Kawamata, H, Nakashiro, K, Omotehara, F, Hino, S, Hoque, M O, Begum, N-M, Yoshida, H, Sato, M, Fujimori, T
Publicado 2001